Manufacturer or GPO Program year 2025 Source: CMS Open Payments

RedDress LTD

Israel

CMS manufacturer 100001448329

Open in the dashboard

General payments

0 payments

Research payments

$1,823,532

58 payments

Ownership & investment interest

None reported

Through program year 2025, RedDress LTD reported paying $0 in general payments and $1,823,532 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows

Research

’21 ’22 ’23 ’24 ’25

Peak $804K

Year	Kind	Amount	Payments
2025	Research	$209,345	10
2024	Research	$439,155	16
2023	Research	$309,488	14
2022	Research	$804,006	14
2021	Research	$61,539	4

Breakdown

Top research recipients Research payments · program year 2025

Cleveland Clinic $81,311 1 payment
Franciscan Health Indianapolis $34,551 1 payment
Mayo Clinic $26,500 1 payment
Southern California Institute for Research and E $17,652 1 payment
The Feinstein Institutes for Medical Research $14,749 1 payment
UMass Chan Medical School $13,364 1 payment
Rhode Island Hospital Teaching hospital · RI $8,391 1 payment
The University of Chicago $5,395 1 payment
Cedars Sinai Medical Center $4,287 1 payment
Allegheny Singer Research Institute (Asri) $3,145 1 payment

Companies with a similar name General payments · program years 2021–2025

RedDress USA, Inc. FL, United States $624,067

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

Records

58 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.